ESMO: Evidence Piles Up For AZ’s Tagrisso With ADAURA CNS Data
But More Mature Data Wanted
Executive Summary
A new analysis of the ADAURA study shows that Tagrisso’s disease-free survival benefits in early stage EGFRm NSCLC are replicated for brain metastases, a common complication with a poor prognosis. Filings and OS data await.